<?xml version="1.0" ?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:seo="http://purl.org/seo/elements/1.0/" version="2.0">
	<channel>
		<title>Telescope Innovations Corp. News Releases</title>
		<link>https://feeds.newsfilecorp.com/company/8923</link>
		<description>Latest news from Telescope Innovations Corp., as distributed by TMX Newsfile.</description>
		<language>en</language>
		<copyright>CopyRight (c) 2026, Newsfile Corp. All Rights Reserved.</copyright>
		<managingEditor>office@newsfilecorp.com (Newsfile Corp.)</managingEditor>
		<webMaster>office@newsfilecorp.com (Newsfile Corp.)</webMaster>
		<lastBuildDate>Wed, 15 Jul 2026 18:26:15 -0400</lastBuildDate>
		<image>
			<url>https://www.newsfilecorp.com/images/newswire/customer-logos/8923.jpg</url>
			<title>Telescope Innovations Corp. News Releases</title>
			<link>https://feeds.newsfilecorp.com/company/8923</link>
		</image>
		<atom:link rel="self" type="application/rss+xml" href="https://feeds.newsfilecorp.com/company/8923"/>
		<item xml:lang="en">
			<title>Telescope Announces Changes to its Board of Directors</title>
			<link>https://www.newsfilecorp.com/release/305206/Telescope-Announces-Changes-to-its-Board-of-Directors</link>
			<description>Vancouver, British Columbia--(Newsfile Corp. - July 14, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of intelligent automation and advanced chemical manufacturing technologies, announces that Ali Pejman has resigned from the Company's Board of Directors ("Board"), effective as of the date of this press release.Henry Dubina, CEO, stated, "On behalf of the Board and management, I would like to thank Ali for his...&lt;img src="https://api.newsfilecorp.com/newsinfo/305206/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Tue, 14 Jul 2026 19:32:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/305206</guid>
		</item>
		<item xml:lang="en">
			<title>Telescope Innovations to Attend Fastmarkets Global Lithium, Battery &amp; Critical Materials in Las Vegas</title>
			<link>https://www.newsfilecorp.com/release/302273/Telescope-Innovations-to-Attend-Fastmarkets-Global-Lithium-Battery-Critical-Materials-in-Las-Vegas</link>
			<description>The Company will use the conference to advance commercial discussions around Self-Driving Labs, automated sampling systems, and lithium sulfide materials licensing Vancouver, British Columbia--(Newsfile Corp. - June 23, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of intelligent automation and advanced chemical manufacturing technologies, is pleased to announce that it will be attending the Fastmarkets Global Lithium,...&lt;img src="https://api.newsfilecorp.com/newsinfo/302273/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Tue, 23 Jun 2026 08:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/302273</guid>
			<atom:subtitle>The Company will use the conference to advance commercial discussions around Self-Driving Labs, automated sampling systems, and lithium sulfide materials licensing</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>Telescope Innovations Provides Financial Results of Third Fiscal Quarter 2026</title>
			<link>https://www.newsfilecorp.com/release/301678/Telescope-Innovations-Provides-Financial-Results-of-Third-Fiscal-Quarter-2026</link>
			<description>Year-to-date revenues are 80% higher than comparative values for previous fiscal year Vancouver, British Columbia--(Newsfile Corp. - June 16, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE:J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended May 31, 2026 (Q3 FY2026). The Company generated revenues of approximately $2.1 million during...&lt;img src="https://api.newsfilecorp.com/newsinfo/301678/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Tue, 16 Jun 2026 08:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/301678</guid>
			<atom:subtitle>Year-to-date revenues are 80% higher than comparative values for previous fiscal year</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>Telescope Innovations to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub</title>
			<link>https://www.newsfilecorp.com/release/300938/Telescope-Innovations-to-Present-at-the-Planet-MicroCap-Las-Vegas-Powered-by-MicroCapClub</link>
			<description>Vancouver, British Columbia--(Newsfile Corp. - June 11, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of intelligent automation and advanced chemical manufacturing technologies, is pleased to announce it will be presenting at the Planet MicroCap Las Vegas 2026 conference on Wednesday, June 17th, 2026. At Planet MicroCap, Dr. Jeffrey Sherman will provide an update on Telescope's business including its DirectInject-LC™...&lt;img src="https://api.newsfilecorp.com/newsinfo/300938/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Thu, 11 Jun 2026 08:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/300938</guid>
		</item>
		<item xml:lang="en">
			<title>Telescope Innovations Founder and CTO, Professor Jason Hein, Receives 2026 SCI Canada LeSueur Memorial Award</title>
			<link>https://www.newsfilecorp.com/release/300261/Telescope-Innovations-Founder-and-CTO-Professor-Jason-Hein-Receives-2026-SCI-Canada-LeSueur-Memorial-Award</link>
			<description>Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") congratulates its Founder and Chief Technology Officer, Professor Jason Hein, on receiving the 2026 SCI Canada LeSueur Memorial Award from the Society of Chemical Industry ("SCI").Figure 1. The 2026 LeSeueur Memorial Award Presented to Professor Jason HeinTo view an enhanced version of this graphic, please...&lt;img src="https://api.newsfilecorp.com/newsinfo/300261/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Fri, 05 Jun 2026 08:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/300261</guid>
		</item>
		<item xml:lang="en">
			<title>Telescope Innovations Secures Third Self-Driving Lab Deployment with Major Global Pharmaceutical Company</title>
			<link>https://www.newsfilecorp.com/release/299526/Telescope-Innovations-Secures-Third-SelfDriving-Lab-Deployment-with-Major-Global-Pharmaceutical-Company</link>
			<description>Continued adoption by world-leading pharmaceutical partners underscores growing industry demand for autonomous lab technology Vancouver, British Columbia--(Newsfile Corp. - June 1, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of intelligent automation and advanced chemical manufacturing technologies, today announced that is has signed  an agreement with a major global pharmaceutical company to deliver a Self-Driving...&lt;img src="https://api.newsfilecorp.com/newsinfo/299526/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Mon, 01 Jun 2026 08:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/299526</guid>
			<atom:subtitle>Continued adoption by world-leading pharmaceutical partners underscores growing industry demand for autonomous lab technology</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>Telescope Innovations Shares Spring 2026 Conference and Events Lineup</title>
			<link>https://www.newsfilecorp.com/release/296847/Telescope-Innovations-Shares-Spring-2026-Conference-and-Events-Lineup</link>
			<description>The Company is actively engaging with pharmaceutical, academic, and investor audiences to strengthen existing and novel partnerships Vancouver, British Columbia--(Newsfile Corp. - May 11, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries. The Company is pleased to report on outreach, marketing, and educational activities,...&lt;img src="https://api.newsfilecorp.com/newsinfo/296847/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Mon, 11 May 2026 08:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/296847</guid>
			<atom:subtitle>The Company is actively engaging with pharmaceutical, academic, and investor audiences to strengthen existing and novel partnerships</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>Telescope Innovations Provides Financial Results of Second Fiscal Quarter 2026</title>
			<link>https://www.newsfilecorp.com/release/292312/Telescope-Innovations-Provides-Financial-Results-of-Second-Fiscal-Quarter-2026</link>
			<description>Revenues are consistent with budget expectations and ahead of Q2 2025 comparative revenues Vancouver, British Columbia--(Newsfile Corp. - April 13, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended February 28, 2026 (Q2 FY2026). The Company generated revenues of approximately $1.6...&lt;img src="https://api.newsfilecorp.com/newsinfo/292312/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Mon, 13 Apr 2026 18:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/292312</guid>
			<atom:subtitle>Revenues are consistent with budget expectations and ahead of Q2 2025 comparative revenues</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>Telescope Innovations Announces Expansion of Consulting Role for Dr. Joel M. Hawkins, Industry Leader in Process Chemistry Automation</title>
			<link>https://www.newsfilecorp.com/release/289035/Telescope-Innovations-Announces-Expansion-of-Consulting-Role-for-Dr.-Joel-M.-Hawkins-Industry-Leader-in-Process-Chemistry-Automation</link>
			<description>Vancouver, British Columbia--(Newsfile Corp. - March 23, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries. The Company is pleased to announce that Dr. Joel M. Hawkins has expanded his consulting role with Telescope. Dr. Hawkins is an industry-wide authority in automating complex chemistry workflows and enabling the...&lt;img src="https://api.newsfilecorp.com/newsinfo/289035/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Mon, 23 Mar 2026 08:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/289035</guid>
		</item>
		<item xml:lang="en">
			<title>Telescope Innovations and AGI SDA Launch Technology Development Collaboration</title>
			<link>https://www.newsfilecorp.com/release/288133/Telescope-Innovations-and-AGI-SDA-Launch-Technology-Development-Collaboration</link>
			<description>The chemistry technology companies aim to develop a next-generation chemical reactor for automated labs Vancouver, British Columbia--(Newsfile Corp. - March 16, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries, with established leadership in sampling systems for monitoring chemical and biological processes. The Company is...&lt;img src="https://api.newsfilecorp.com/newsinfo/288133/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Mon, 16 Mar 2026 08:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/288133</guid>
			<atom:subtitle>The chemistry technology companies aim to develop a next-generation chemical reactor for automated labs</atom:subtitle>
		</item>
	</channel>
</rss>
